BlueMedix
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BlueMedix - overview
Established
2017
Location
Bangalore, Karnataka, India
Primary Industry
Retail
About
Founded in 2017 and based in Karnataka, India, BlueMedix specializes in advanced healthcare technology. The company was founded by its CEO, Azam Rais. In January 2025, BlueMedix raised USD 5 million in pre-series A funding led by investors. BlueMedix focuses on delivering comprehensive healthcare solutions through medical devices and healthcare management platforms.
The company’s offerings include advanced telemedicine systems for remote patient monitoring and consultation, targeting chronic disease management and post-operative care. The firm’s clients include hospitals, outpatient clinics, and individual practitioners, with products marketed in North America and several European countries. The company generates revenue through a structured model that involves both direct sales and subscription services. The company engages in B2B transactions with healthcare facilities, providing tailored packages that combine hardware and software solutions for telemedicine and patient management.
Additionally, partnerships with healthcare providers contribute to revenue through a share of generated service income. The organization plans to use the January 2025 funding to expand into new territories, set up a central warehouse in Delhi NCR, and scale operations through recruitment, marketing, and customer-focused innovations.
Primary Industry
Retail
Sub Industries
Drug Stores/Convenience Stores, Pharmaceuticals, Internet
Verticals
E-commerce, Mobile Apps
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
BlueMedix - financials
| Fiscal Year Ended | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 |
|---|---|---|---|
| Revenue (USD) | - | - | - |
| % Revenue Growth (YoY) | - | - | - |
| EBITDA (USD) | - | - | - |
| Operating Income (USD) | - | - | - |
| Operating Margin | - | - | - |
| % EBITDA Margin | - | - | - |
| NET Income (USD) | - | - | - |
| % Net Margin | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.